- Brisbane, California, United States
- Hybrid
- Full-time · Director
- 10+ years
Lead the scale-up of lipid nanoparticle (LNP) drug product process from Phase 1 into Phase 2 and toward late stage readiness, owning the technical path from clinical process to a well-characterized, scalable process ready for PPQ.
Responsibilities
- Lead scale-up of the Phase 1 LNP process (nucleic acid payload formulation, mixing, buffer exchange/TFF, sterile filtration and fill) to Phase 2 and late-stage clinical scale
- Define the scale-up strategy, including equipment selection, mixing platform scalability, scale-down model development and comparability between process versions
- Plan and execute technology transfers of processes and methods between Mammoth, development partners and GMP CDMOs
- Own the technical risk assessments (e.g., FMEA) that drive scale-up and characterization priorities
- Build the control strategy using a QbD approach: define CQAs and CPPs, link material attributes to product quality, and set proven acceptable ranges
Requirements
- PhD in chemical engineering, pharmaceutical sciences, chemistry or a related field
- MS with 14+ years of industry experience
- BS with 16+ years of industry experience
- Nice to have: mRNA/LNP experience
- Nice to have: Gene editing drug products
